LEAH NICOLE QUACH: Open Payments
NPI 1669006508 · LONG ISLAND CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 41 payments from 14 companies in 2025. Trend: 2023 $1,168 · 2024 $2,056 · 2025 $1,096
Food & beverage: $1,096
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $236 |
| Incyte Corporation | 7 | $233 |
| UCB, Inc. | 4 | $101 |
| ABBVIE INC. | 4 | $86 |
| LEO Pharma Inc. | 3 | $71 |
| Galderma Laboratories, L.P. | 4 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Organon LLC | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $40 |
Products named: DUPIXENT, OPZELURA, Bimzelx, SKYRIZI, ADBRY, NEMLUVIO, COSENTYX, VTAMA.
Industry payments across NY — which companies pay providers there.
